Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Bile Duct Disorder”

13,263 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 13,263 results

Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Testing effectiveness (Phase 2)Study completedNCT00415051
What this trial is testing

Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine

Who this might be right for
Rift Valley Fever
U.S. Army Medical Research and Development Command 20
Not applicableUnknownNCT02493153
What this trial is testing

Hepatic Steatosis After Cholecystectomy

Who this might be right for
Hepatic Steatosis
Sangchul Yun 82
Not applicableUnknownNCT03730675
What this trial is testing

Irradiation Stent Placement Plus TACE for HCC and PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Zhongda Hospital 308
Testing effectiveness (Phase 2)Study completedNCT03976401
What this trial is testing

Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc 110
Large-scale testing (Phase 3)Not Yet RecruitingNCT06691412
What this trial is testing

Obeticholic Acid Among Chronic HBV Patients with Hepatic Steatosis : Clinical and Portal Doppler Outcomes

Who this might be right for
Hepatitis B VirusSteatosis
Assiut University 100
Not applicableNot Yet RecruitingNCT07433881
What this trial is testing

Serosurvey of HAV Immunity and Single-dose Vaccine Immunogenicity Among Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
Institute of Liver and Biliary Sciences, India 360
Testing effectiveness (Phase 2)Study completedNCT06233981
What this trial is testing

Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaRadiotherapyTislelizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Not applicableUnknownNCT03754400
What this trial is testing

Efficacy of Albumin Therapy With Standard Medical Treatment (SMT) as Compared to Standard Medical Treatment (SMT) in Improving Patient Survival and Immune Modulation in Patients With Acute on Chronic Liver Failure (ASIA Trial).

Who this might be right for
Acute on Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 200
Testing effectiveness (Phase 2)Study completedNCT00537407
What this trial is testing

Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment

Who this might be right for
Chronic Hepatitis C
Debiopharm International SA 50
Not applicableNo Longer AvailableNCT02477345
What this trial is testing

Compassionate Use of Omegaven IV Fat Emulsion

Who this might be right for
CholestasisLiver Disease
Northwell Health
Testing effectiveness (Phase 2)Study completedNCT00797745
What this trial is testing

A Pharmacokinetics/Pharmacodynamics Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104AM2)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 111
Not applicableStudy completedNCT06550739
What this trial is testing

Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Haike Lei 1,053
Not applicableStudy completedNCT01726439
What this trial is testing

Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb 3,434
Not applicableWithdrawnNCT03302481
What this trial is testing

Mitochondrial Metabolism and Hepatic Complications of Obesity

Who this might be right for
Obesity
Nantes University Hospital
Not applicableStudy completedNCT03740230
What this trial is testing

An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs

Who this might be right for
Hepatitis C
AbbVie 3,134
Large-scale testing (Phase 3)UnknownNCT01270165
What this trial is testing

Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Yonsei University 110
Not applicableUnknownNCT03694600
What this trial is testing

Clinical Trial Multi-analyte Blood Test

Who this might be right for
Liver Cirrhosis
Helio Genomics 1,900
Large-scale testing (Phase 3)Study completedNCT02671500
What this trial is testing

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 375
Not applicableUnknownNCT03181607
What this trial is testing

Efficacy and Adverse Effects of Nucleoside Analogues (TDF/LDT) in Preventing Mother-to-child Transmission of HBV

Who this might be right for
Chronic Hepatitis bWomen
Xingfei Pan 300
Load More Results